Information About HIV Transmission and Circumcision on Subsequent Sexual Behavior, and the Demand for Circumcision
NCT ID: NCT01895556
Last Updated: 2013-07-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1200 participants
INTERVENTIONAL
2008-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating Demand Creation Strategies for Voluntary Medical Male Circumcision (VMMC) in Kenya
NCT02497989
Efficacy of an Abstinence-Only HIV Risk-Reduction Intervention for Young African-American Adolescents
NCT00640653
Increasing Availability and Acceptability of Circumcision in Zambia
NCT01688167
Manicaland VMMC Uptake Through Behavioural Incentives Trial
NCT03565588
Strategies to Increase HIV Testing, Linkages to Care, and Male Circumcision in Africa
NCT02038582
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Information
Information about male circumcision and HIV risk
Information
Control
Control
Control
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Information
Control
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
25 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rebecca Thornton
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rebecca Thornton
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rebecca Thornton, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Susan Godlonton, PhD
Role: STUDY_DIRECTOR
University of Michigan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FSG09-Thornton
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.